Latest filing published 11 Aug 2021 for Rossari Biotech Limited, €6,259.
Filing timeline
BuySaleSandeep Shanbhag: trading record in brief
Sandeep Shanbhag (chief executive) discloses dealings in Rossari Biotech Limited to SEBI (PIT + SAST). Over a trading history stretching from 17 July 2021 to 10 August 2021, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 11 August 2021 came the latest disclosure, a transaction for €6,259 in Rossari Biotech Limited. Typically, a trade is published a median of 1 day after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sandeep Shanbhag
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400 shares@ ₹1,366.300.0000% mcap9.8% of flowEquity SharesSEBI:977e3441a347f242d77b2211b902884e0b8e71d1
- 1,350 shares@ ₹1,289.14960.0001% mcap31.0% of flowEquity SharesSEBI:7287398343937e823454b46036a709bf6bd39002
- 1,350 shares@ ₹1,289.14960.0001% mcap31.0% of flowEquity SharesSEBI:1d9137491468a760602593400c94fc72f6676f56
- 1,350 shares@ ₹1,167.45040.0001% mcap28.1% of flowEquity SharesSEBI:1d2a76937fb3b24928cfd61032e96473f024cd2fCanonical exit: 15 Oct 2021 (T+90)
4 of 4 declarations